International Journal of Infertility & Fetal Medicine

Register      Login

VOLUME 13 , ISSUE 3 ( September-December, 2022 ) > List of Articles


Comparison of Endocrine and Metabolic Profile of Obese and Lean PCOS Women with Infertility

Pragya Gupta, Smriti Agrawal, Anjoo Agarwal, Amita Pandey, Namrata Kumar

Keywords : Metabolic syndrome, Obesity, Polycystic ovary syndrome

Citation Information : Gupta P, Agrawal S, Agarwal A, Pandey A, Kumar N. Comparison of Endocrine and Metabolic Profile of Obese and Lean PCOS Women with Infertility. Int J Infertil Fetal Med 2022; 13 (3):125-128.

DOI: 10.5005/jp-journals-10016-1290

License: CC BY-NC 4.0

Published Online: 29-12-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Background: Polycystic ovary syndrome (PCOS) has been associated with endocrine and metabolic abnormalities. The study’s objective was to compare the endocrine and metabolic parameters of lean and obese PCOS women with infertility. Materials and methods: After satisfying the inclusion and exclusion criteria, infertile women with PCOS were enrolled in the study. Women were divided into two groups according to their body mass index (BMI); group I with BMI <23 kg/m2 (lean and underweight) and group II with BMI ≥ 23 kg/m2 (obese and overweight) according to the Indian Council of Medical Research (ICMR) guidelines. Physical characteristics like the presence of acne, hirsutism, acanthosis nigricans (AN), and waist–hip ratio (WHR) were noted in all. The endocrine profile included serum levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), anti-Müllerian hormone (AMH), thyroid-stimulating hormone, prolactin, estradiol, and testosterone, while the metabolic profile included lipid profile, oral glucose tolerance test (OGTT) (fasting and 2 hours), fasting insulin. Results: A total of 80 women were enrolled. Obese PCOS had hypertriglyceridemia (15% vs 0% in lean group, p = 0.011) and hypercholesterolemia (20% vs 2.5%, p = 0.011). AN, acne, hirsutism, hormonal profile (LH/FSH ratio, AMH, serum testosterone), fasting insulin, and OGTT were similar in both groups. Conclusion: Increased BMI in PCOS women is associated with increased WHR and altered lipid profile with no difference in endocrine parameters.

  1. Barthelmess EK, Naz RK. Polycystic ovary syndrome: current status and future perspective. Front Biosci (Elite Ed) 2014;6(1):104–119. DOI: 10.2741/e695
  2. Majumdar A, Singh TA. Comparison of clinical features and health manifestations in lean vs. obese Indian women with polycystic ovarian syndrome. J Hum Reprod Sci 2009;2(1):12–17. DOI: 10.4103/0974-1208.51336
  3. Kar S. Anthropometric, clinical, and metabolic comparisons of the four Rotterdam PCOS phenotypes: A prospective study of PCOS women. J Hum Reprod Sci 2013;6(3):194–200. DOI: 10.4103/0974-1208.121422
  4. Pikee S, Shivani S, Jayshree B. Endocrine and metabolic profile of different phenotypes of polycystic ovarian syndrome. J Obstet Gynaecol India 2016;66(Suppl 1):560–566. DOI: 10.1007/s13224-016-0898-7
  5. Khomami MB, Tehrani FR, Hashemi S, et al. Of PCOS symptoms, hirsutism has the most significant impact on the quality of life of Iranian women. PLoS One 2015;10(4):e0123608. DOI: 10.1371/journal.pone.0123608
  6. G S, A B, Kamath A, et al. Acanthosis nigricansin PCOS patients and its relation with type 2 diabetes mellitus and body mass at a tertiary care hospital in Southern India. J Clin Diagn Res 2013;7(2):317–319. DOI: 10.7860/JCDR/2013/4930.2756
  7. Saxena P, Prakash A, Nigam A, et al. Polycystic ovary syndrome: is obesity a sine qua non? A clinical, hormonal, and metabolic assessment in relation to body mass index. Indian J Endocrinol Metab 2012;16(6):996–999. DOI: 10.4103/2230-8210.103011
  8. Saadia Z. Follicle stimulating hormone (LH: FSH) ratio in polycystic ovary syndrome (PCOS) - obese vs. non-obese women. Med Arch 2020;74(4):289–293. DOI: 10.5455/medarh.2020.74.289-293
  9. McManus SS, Levitsky LL, Misra M. Polycystic ovary syndrome: clinical presentation in normal-weight compared with overweight adolescents. Endocr Pract 2013;19(3):471–418. DOI: 10.4158/EP12235.OR
  10. Lal L, Bharti A, Perween A. To study the status of LH: FSH ratio in obese and non-obese patients of polycystic ovarian syndrome. IOSR J Dent Med Sci 2017;16(1):20–23. DOI: 10.9790/0853-1601012023
  11. Khan SH, Rizvi SA, Shahid R, et al. Dehydroepiandrosterone sulfate (DHEAS) levels in polycystic ovarian syndrome (PCOS). J Coll Physicians Surg Pak 2021;31(3):253–257. DOI: 10.29271/jcpsp.2021.03.253
  12. Cassar S, Teede HJ, Moran LJ, et al. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins. Clin Endocrinol (Oxf) 2014;81(6):899–906. DOI: 10.1111/cen.12557
  13. Kriseman M, Mills C, Kovanci E, et al. Antimullerian hormone levels are inversely associated with body mass index (BMI) in women with polycystic ovary syndrome. J Assist Reprod Genet 2015;32(9):1313–1316. DOI: 10.1007/s10815-015-0540-0
  14. Barber TM, Dimitriadis GK, Andreou A, et al. Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance. Clin Med (Lond) 2016;16(3):262–266. DOI: 10.7861/clinmedicine.16-3-262
  15. Vrbíková J, Cibula D, Dvoráková K, et al. Insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004;89(6):2942–2945. DOI: 10.1210/jc.2003-031378
  16. Goyal M, Dawood AS. Debates regarding lean patients with polycystic ovary syndrome: a narrative review. J Hum Reprod Sci 2017;10(3):154–161. DOI: 10.4103/jhrs.JHRS_77_17
  17. Stovall DW, Bailey AP, Pastore LM. Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome. J Womens Health (Larchmt) 2011;20(1):37–43. DOI: 10.1089/jwh.2010.2053
  18. Faloia E, Canibus P, Gatti C, et al. Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome. J Endocrinol Invest 2004;27(5):424–429. DOI: 10.1007/BF03345285
  19. Gholinezhad M, Gholsorkhtabaramiri M, Esmaeilzadeh S, et al. Insulin resistance and adverse metabolic profile in overweight/obese and normal weight of young women with polycystic ovary syndrome. Caspian J Intern Med 2018;9(3):260–267. DOI: 10.22088/cjim.9.3.260
  20. Cupisti S, Haeberle L, Schell C, et al. The different phenotypes of polycystic ovary syndrome: no advantages for identifying women with aggravated insulin resistance or impaired lipids. Exp Clin Endocrinol Diabetes 2011;119(8):502–508. DOI: 10.1055/s-0031-1277136
  21. Layegh P, Mousavi Z, Tehrani DF, et al. Insulin resistance and endocrine-metabolic abnormalities in polycystic ovarian syndrome: comparison between obese and non-obese PCOS patients. Int J Reprod Biomed 2016;14(4):263–270. DOI: 10.29252/ijrm.14.4.263
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.